

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 5.97467417 |
| 2 | tricarboxylic acid cycle (GO:0006099) | 5.75231826 |
| 3 | actin-myosin filament sliding (GO:0033275) | 5.59455268 |
| 4 | muscle filament sliding (GO:0030049) | 5.59455268 |
| 5 | carnitine shuttle (GO:0006853) | 5.53977773 |
| 6 | lysine metabolic process (GO:0006553) | 5.30032432 |
| 7 | lysine catabolic process (GO:0006554) | 5.30032432 |
| 8 | skeletal muscle adaptation (GO:0043501) | 5.26425753 |
| 9 | 2-oxoglutarate metabolic process (GO:0006103) | 5.24125283 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 5.22026867 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 5.20039542 |
| 12 | skeletal muscle fiber development (GO:0048741) | 5.00223268 |
| 13 | response to muscle activity (GO:0014850) | 4.98789004 |
| 14 | cardiac myofibril assembly (GO:0055003) | 4.89199991 |
| 15 | myofibril assembly (GO:0030239) | 4.89111654 |
| 16 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.78680171 |
| 17 | fatty acid beta-oxidation (GO:0006635) | 4.77842977 |
| 18 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.74780267 |
| 19 | aspartate family amino acid catabolic process (GO:0009068) | 4.68604680 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.61980741 |
| 21 | gluconeogenesis (GO:0006094) | 4.57345952 |
| 22 | actin-mediated cell contraction (GO:0070252) | 4.48972929 |
| 23 | regulation of sequestering of triglyceride (GO:0010889) | 4.48153716 |
| 24 | valine metabolic process (GO:0006573) | 4.33092337 |
| 25 | muscle contraction (GO:0006936) | 4.33037295 |
| 26 | myotube cell development (GO:0014904) | 4.30702776 |
| 27 | NADH metabolic process (GO:0006734) | 4.29844637 |
| 28 | carnitine transmembrane transport (GO:1902603) | 4.29676376 |
| 29 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.29332525 |
| 30 | creatine metabolic process (GO:0006600) | 4.29071267 |
| 31 | fatty acid catabolic process (GO:0009062) | 4.23946465 |
| 32 | cardiac muscle contraction (GO:0060048) | 4.23204058 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.22803633 |
| 34 | fatty acid oxidation (GO:0019395) | 4.21220520 |
| 35 | plasma membrane repair (GO:0001778) | 4.20634323 |
| 36 | hexose biosynthetic process (GO:0019319) | 4.16463192 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.14203438 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 4.13955162 |
| 39 | response to inactivity (GO:0014854) | 4.13901225 |
| 40 | branched-chain amino acid catabolic process (GO:0009083) | 4.12336321 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.12050294 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 4.12050294 |
| 43 | lipid oxidation (GO:0034440) | 4.11972150 |
| 44 | carnitine transport (GO:0015879) | 4.10493999 |
| 45 | amino-acid betaine transport (GO:0015838) | 4.10493999 |
| 46 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.10220419 |
| 47 | oxaloacetate metabolic process (GO:0006107) | 4.08822078 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 4.04208714 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.04208714 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.03731871 |
| 51 | glyoxylate metabolic process (GO:0046487) | 4.03508679 |
| 52 | fructose metabolic process (GO:0006000) | 4.03282660 |
| 53 | striated muscle atrophy (GO:0014891) | 4.01990459 |
| 54 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.01610634 |
| 55 | regulation of fatty acid oxidation (GO:0046320) | 4.00474202 |
| 56 | negative regulation of cell size (GO:0045792) | 3.99880918 |
| 57 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99586663 |
| 58 | acetyl-CoA metabolic process (GO:0006084) | 3.98810747 |
| 59 | succinate metabolic process (GO:0006105) | 3.96117961 |
| 60 | tricarboxylic acid metabolic process (GO:0072350) | 3.95898582 |
| 61 | branched-chain amino acid metabolic process (GO:0009081) | 3.92693925 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 3.88257270 |
| 63 | regulation of cofactor metabolic process (GO:0051193) | 3.88257270 |
| 64 | monosaccharide biosynthetic process (GO:0046364) | 3.85983729 |
| 65 | carnitine metabolic process (GO:0009437) | 3.83417060 |
| 66 | striated muscle contraction (GO:0006941) | 3.82508702 |
| 67 | monocarboxylic acid catabolic process (GO:0072329) | 3.82125675 |
| 68 | muscle system process (GO:0003012) | 3.82042907 |
| 69 | cellular polysaccharide catabolic process (GO:0044247) | 3.79519591 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 3.78426989 |
| 71 | kynurenine metabolic process (GO:0070189) | 3.77165024 |
| 72 | cardiac muscle cell development (GO:0055013) | 3.72974135 |
| 73 | muscle cell fate commitment (GO:0042693) | 3.70986981 |
| 74 | skeletal muscle contraction (GO:0003009) | 3.69367225 |
| 75 | muscle atrophy (GO:0014889) | 3.67267587 |
| 76 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.64531906 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 3.63638905 |
| 78 | oxidative phosphorylation (GO:0006119) | 3.63165200 |
| 79 | regulation of actin filament-based movement (GO:1903115) | 3.62938154 |
| 80 | striated muscle adaptation (GO:0014888) | 3.60430958 |
| 81 | muscle organ morphogenesis (GO:0048644) | 3.60243014 |
| 82 | actomyosin structure organization (GO:0031032) | 3.59670105 |
| 83 | biotin metabolic process (GO:0006768) | 3.58775401 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.58267892 |
| 85 | ethanol oxidation (GO:0006069) | 3.55013310 |
| 86 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.53839923 |
| 87 | positive regulation of fatty acid oxidation (GO:0046321) | 3.51249447 |
| 88 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.49999422 |
| 89 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.49221406 |
| 90 | positive regulation of myotube differentiation (GO:0010831) | 3.48216310 |
| 91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.47679913 |
| 92 | cardiac cell development (GO:0055006) | 3.46476452 |
| 93 | glycogen catabolic process (GO:0005980) | 3.46081328 |
| 94 | ketone body metabolic process (GO:1902224) | 3.45993658 |
| 95 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.45954157 |
| 96 | proline biosynthetic process (GO:0006561) | 3.45149041 |
| 97 | alpha-linolenic acid metabolic process (GO:0036109) | 3.43894945 |
| 98 | respiratory electron transport chain (GO:0022904) | 3.42513842 |
| 99 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41299282 |
| 100 | aromatic amino acid family catabolic process (GO:0009074) | 3.41163511 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.39582598 |
| 102 | quaternary ammonium group transport (GO:0015697) | 3.38688522 |
| 103 | muscle cell cellular homeostasis (GO:0046716) | 3.37584346 |
| 104 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.37249469 |
| 105 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.35658561 |
| 106 | ubiquinone biosynthetic process (GO:0006744) | 3.34538376 |
| 107 | polysaccharide catabolic process (GO:0000272) | 3.34084649 |
| 108 | electron transport chain (GO:0022900) | 3.32936077 |
| 109 | regulation of sulfur metabolic process (GO:0042762) | 3.32095529 |
| 110 | heart contraction (GO:0060047) | 3.31659547 |
| 111 | heart process (GO:0003015) | 3.31659547 |
| 112 | skeletal muscle tissue development (GO:0007519) | 3.30843678 |
| 113 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.30776982 |
| 114 | glycogen metabolic process (GO:0005977) | 3.29906474 |
| 115 | actin filament-based movement (GO:0030048) | 3.28316943 |
| 116 | glucan catabolic process (GO:0009251) | 3.26757517 |
| 117 | muscle fiber development (GO:0048747) | 3.26461239 |
| 118 | cardiac muscle hypertrophy (GO:0003300) | 3.25684694 |
| 119 | adult heart development (GO:0007512) | 3.25486270 |
| 120 | glycolytic process (GO:0006096) | 3.23542262 |
| 121 | glucan metabolic process (GO:0044042) | 3.20021752 |
| 122 | cellular glucan metabolic process (GO:0006073) | 3.20021752 |
| 123 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.19946077 |
| 124 | IMP metabolic process (GO:0046040) | 3.19353435 |
| 125 | heart trabecula formation (GO:0060347) | 3.19200936 |
| 126 | muscle tissue morphogenesis (GO:0060415) | 3.18021337 |
| 127 | cysteine metabolic process (GO:0006534) | 3.17079739 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 3.14967029 |
| 129 | organic acid catabolic process (GO:0016054) | 3.14967029 |
| 130 | striated muscle hypertrophy (GO:0014897) | 3.13702228 |
| 131 | glycogen biosynthetic process (GO:0005978) | 3.13680756 |
| 132 | glucan biosynthetic process (GO:0009250) | 3.13680756 |
| 133 | regulation of cell communication by electrical coupling (GO:0010649) | 3.13678376 |
| 134 | muscle adaptation (GO:0043500) | 3.12613144 |
| 135 | negative regulation of necroptotic process (GO:0060546) | 3.11111574 |
| 136 | glucose metabolic process (GO:0006006) | 2.96782992 |
| 137 | muscle hypertrophy (GO:0014896) | 2.93801515 |
| 138 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.90784781 |
| 139 | muscle organ development (GO:0007517) | 2.88787195 |
| 140 | muscle structure development (GO:0061061) | 2.84215088 |
| 141 | ubiquinone metabolic process (GO:0006743) | 2.83031373 |
| 142 | AMP metabolic process (GO:0046033) | 2.82887958 |
| 143 | purine nucleotide salvage (GO:0032261) | 2.80379815 |
| 144 | focal adhesion assembly (GO:0048041) | 2.74539977 |
| 145 | cell-substrate adherens junction assembly (GO:0007045) | 2.74539977 |
| 146 | quinone biosynthetic process (GO:1901663) | 2.74519934 |
| 147 | mitochondrial fusion (GO:0008053) | 2.72853654 |
| 148 | skeletal muscle tissue regeneration (GO:0043403) | 2.72362019 |
| 149 | regulation of the force of heart contraction (GO:0002026) | 2.67974647 |
| 150 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.67044226 |
| 151 | striated muscle cell development (GO:0055002) | 2.66474291 |
| 152 | galactose catabolic process (GO:0019388) | 2.65898561 |
| 153 | regulation of striated muscle contraction (GO:0006942) | 2.62906256 |
| 154 | nucleotide salvage (GO:0043173) | 2.59657413 |
| 155 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59330276 |
| 156 | cellular carbohydrate biosynthetic process (GO:0034637) | 2.57299973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.89610569 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.75635469 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.40284636 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.03374663 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.19066445 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.17633859 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.57045310 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.20584350 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.97539481 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91765587 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84585292 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.71488005 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61144617 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.35776026 |
| 15 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.35776026 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28951542 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.24614109 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19603126 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.15000413 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.03740669 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92254462 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.89188330 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.84091159 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.83738606 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79679117 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78550369 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76802370 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75557225 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74386900 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.73571058 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72105092 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70540998 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.67343910 |
| 34 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.66403735 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63583117 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63195755 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59664967 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59327929 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58353282 |
| 40 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54768926 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53828913 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52432699 |
| 43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.48653824 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45072176 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44894134 |
| 46 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42934682 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40852130 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37563834 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33983290 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33569989 |
| 51 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33557454 |
| 52 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.32154135 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28639892 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28474070 |
| 55 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28315766 |
| 56 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.27860466 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27043265 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26934949 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25962800 |
| 60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25229156 |
| 61 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.24741516 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24628903 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24093928 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21457680 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20697009 |
| 66 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.20435380 |
| 67 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.17229222 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16679976 |
| 69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.16407773 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15884354 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14065351 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14037484 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12752481 |
| 74 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12320203 |
| 75 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11939863 |
| 76 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11757879 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11652624 |
| 78 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10834515 |
| 79 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10459096 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10303191 |
| 81 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10136053 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.10074158 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09620417 |
| 84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09378793 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09062857 |
| 86 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08821994 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08771085 |
| 88 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08731769 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08034219 |
| 90 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08020605 |
| 91 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.07947607 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07946355 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07850043 |
| 94 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07195746 |
| 95 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07160658 |
| 96 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06831217 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06456775 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06347303 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06195940 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05573436 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05392191 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03134024 |
| 103 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02542600 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01314080 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00731247 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00622105 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00166083 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94486379 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92755729 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92658239 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91986649 |
| 112 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89538639 |
| 113 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89475720 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88059376 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86384060 |
| 116 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84178500 |
| 117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83370579 |
| 118 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83320382 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83051925 |
| 120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.82852592 |
| 121 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.82820510 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82597269 |
| 123 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82543295 |
| 124 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.82192507 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81942202 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81814163 |
| 127 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.81542629 |
| 128 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80865051 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80500836 |
| 130 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.80418892 |
| 131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79961059 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79930788 |
| 133 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.79535250 |
| 134 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78078564 |
| 135 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.78046333 |
| 136 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.77669025 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76732943 |
| 138 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.76078831 |
| 139 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76033091 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75263099 |
| 141 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75116200 |
| 142 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.73894957 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73302635 |
| 144 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73106949 |
| 145 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72967773 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72958238 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72900890 |
| 148 | MAF_26560356_Chip-Seq_TH1_Human | 0.72811880 |
| 149 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72328906 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71188191 |
| 151 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.70866713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.54129727 |
| 2 | MP0003646_muscle_fatigue | 5.35751027 |
| 3 | MP0000751_myopathy | 4.23294820 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.65206768 |
| 5 | MP0000749_muscle_degeneration | 3.64224953 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.60805319 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.43616331 |
| 8 | MP0005360_urolithiasis | 3.20859530 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.15574741 |
| 10 | MP0005330_cardiomyopathy | 3.07440433 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.06585196 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.99352659 |
| 13 | MP0004130_abnormal_muscle_cell | 2.95471030 |
| 14 | MP0005365_abnormal_bile_salt | 2.90833963 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.64248699 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.55677123 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.42906673 |
| 18 | MP0002269_muscular_atrophy | 2.31930353 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.29109980 |
| 20 | MP0000747_muscle_weakness | 2.26644105 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.21930015 |
| 22 | MP0005620_abnormal_muscle_contractility | 2.18521448 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17879259 |
| 24 | MP0002972_abnormal_cardiac_muscle | 2.11201856 |
| 25 | MP0005083_abnormal_biliary_tract | 1.96790917 |
| 26 | MP0009840_abnormal_foam_cell | 1.93994479 |
| 27 | MP0000759_abnormal_skeletal_muscle | 1.91713789 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.89605197 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.88816901 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.88816901 |
| 31 | MP0003137_abnormal_impulse_conducting | 1.88777593 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.86694343 |
| 33 | MP0005369_muscle_phenotype | 1.82259746 |
| 34 | MP0003252_abnormal_bile_duct | 1.78625629 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.77751097 |
| 36 | MP0005670_abnormal_white_adipose | 1.73011281 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.69392236 |
| 38 | MP0005332_abnormal_amino_acid | 1.63015670 |
| 39 | MP0003195_calcinosis | 1.61633920 |
| 40 | MP0006138_congestive_heart_failure | 1.57914472 |
| 41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.56991924 |
| 42 | MP0004484_altered_response_of | 1.56883500 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.45629568 |
| 44 | MP0001661_extended_life_span | 1.43675405 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.37314004 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.34931200 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.30292353 |
| 48 | MP0004233_abnormal_muscle_weight | 1.27815883 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.27387666 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.27129195 |
| 51 | MP0004085_abnormal_heartbeat | 1.23529072 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.22337063 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20974676 |
| 54 | MP0002971_abnormal_brown_adipose | 1.19628469 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.18974210 |
| 56 | MP0000609_abnormal_liver_physiology | 1.17342710 |
| 57 | MP0003828_pulmonary_edema | 1.16680503 |
| 58 | MP0003123_paternal_imprinting | 1.16507834 |
| 59 | MP0004858_abnormal_nervous_system | 1.15419011 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.14961551 |
| 61 | MP0005266_abnormal_metabolism | 1.13930647 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.10166416 |
| 63 | MP0005451_abnormal_body_composition | 1.10016929 |
| 64 | MP0010030_abnormal_orbit_morphology | 1.09354378 |
| 65 | MP0000343_altered_response_to | 1.06396864 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.06074724 |
| 67 | MP0002249_abnormal_larynx_morphology | 1.04921260 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.01378421 |
| 69 | MP0004510_myositis | 0.97040302 |
| 70 | MP0004043_abnormal_pH_regulation | 0.96634005 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.95442405 |
| 72 | MP0000678_abnormal_parathyroid_gland | 0.95405971 |
| 73 | MP0009643_abnormal_urine_homeostasis | 0.94602579 |
| 74 | MP0009672_abnormal_birth_weight | 0.93468437 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.91359036 |
| 76 | MP0010368_abnormal_lymphatic_system | 0.86241745 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.86090111 |
| 78 | MP0003186_abnormal_redox_activity | 0.85584071 |
| 79 | MP0000230_abnormal_systemic_arterial | 0.82080604 |
| 80 | MP0005165_increased_susceptibility_to | 0.82025033 |
| 81 | MP0004147_increased_porphyrin_level | 0.79385857 |
| 82 | MP0005535_abnormal_body_temperature | 0.78728777 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.77407058 |
| 84 | MP0005334_abnormal_fat_pad | 0.77194332 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.75099379 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.73986251 |
| 87 | MP0004270_analgesia | 0.73751502 |
| 88 | MP0002108_abnormal_muscle_morphology | 0.72535525 |
| 89 | MP0001764_abnormal_homeostasis | 0.72028990 |
| 90 | MP0000266_abnormal_heart_morphology | 0.71808455 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70446401 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.68351553 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 0.67480904 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.65603263 |
| 95 | MP0005501_abnormal_skin_physiology | 0.61899088 |
| 96 | MP0001853_heart_inflammation | 0.60358868 |
| 97 | MP0000003_abnormal_adipose_tissue | 0.59640560 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.58934977 |
| 99 | MP0000598_abnormal_liver_morphology | 0.58605494 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.57152468 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.56865685 |
| 102 | MP0002128_abnormal_blood_circulation | 0.55381229 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.54516200 |
| 104 | MP0000733_abnormal_muscle_development | 0.54006626 |
| 105 | MP0003868_abnormal_feces_composition | 0.53652832 |
| 106 | MP0000537_abnormal_urethra_morphology | 0.53070210 |
| 107 | MP0003279_aneurysm | 0.51052366 |
| 108 | MP0008260_abnormal_autophagy | 0.50749122 |
| 109 | MP0002114_abnormal_axial_skeleton | 0.50472068 |
| 110 | MP0002970_abnormal_white_adipose | 0.50404179 |
| 111 | MP0009115_abnormal_fat_cell | 0.50398361 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.49952817 |
| 113 | MP0002796_impaired_skin_barrier | 0.49286945 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.49121113 |
| 115 | MP0009763_increased_sensitivity_to | 0.48874839 |
| 116 | MP0001849_ear_inflammation | 0.48762413 |
| 117 | MP0003879_abnormal_hair_cell | 0.48727320 |
| 118 | MP0001730_embryonic_growth_arrest | 0.48566287 |
| 119 | MP0009278_abnormal_bone_marrow | 0.47698308 |
| 120 | MP0003315_abnormal_perineum_morphology | 0.47188859 |
| 121 | MP0003111_abnormal_nucleus_morphology | 0.47022604 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.46948903 |
| 123 | MP0008469_abnormal_protein_level | 0.45796165 |
| 124 | MP0005448_abnormal_energy_balance | 0.45661264 |
| 125 | MP0000467_abnormal_esophagus_morphology | 0.44935927 |
| 126 | MP0002822_catalepsy | 0.44109414 |
| 127 | MP0005452_abnormal_adipose_tissue | 0.43101451 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.41801064 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.41645146 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.40358056 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.39251899 |
| 132 | MP0002080_prenatal_lethality | 0.38896212 |
| 133 | MP0008932_abnormal_embryonic_tissue | 0.37553827 |
| 134 | MP0010094_abnormal_chromosome_stability | 0.37336928 |
| 135 | MP0004197_abnormal_fetal_growth/weight/ | 0.36222923 |
| 136 | MP0003959_abnormal_lean_body | 0.35670957 |
| 137 | MP0003984_embryonic_growth_retardation | 0.35501791 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.35281718 |
| 139 | MP0000372_irregular_coat_pigmentation | 0.32732580 |
| 140 | MP0002088_abnormal_embryonic_growth/wei | 0.32216525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.96966369 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.52116458 |
| 3 | Myoglobinuria (HP:0002913) | 5.33009012 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.32412050 |
| 5 | Sudden death (HP:0001699) | 5.31346375 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.23710681 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.94925875 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.65470129 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.61613314 |
| 10 | Rhabdomyolysis (HP:0003201) | 4.29903662 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 4.25388150 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.17680544 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 3.89891451 |
| 14 | Calcaneovalgus deformity (HP:0001848) | 3.83045007 |
| 15 | Subaortic stenosis (HP:0001682) | 3.78261597 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.78261597 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.77382304 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.76986496 |
| 19 | Ketosis (HP:0001946) | 3.74879606 |
| 20 | Ketoacidosis (HP:0001993) | 3.74071984 |
| 21 | Palpitations (HP:0001962) | 3.70550500 |
| 22 | Lipoatrophy (HP:0100578) | 3.69683277 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.68565278 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.66340503 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.63150492 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 3.57985484 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.56094047 |
| 28 | Difficulty running (HP:0009046) | 3.51686599 |
| 29 | Atrial fibrillation (HP:0005110) | 3.49127308 |
| 30 | Increased connective tissue (HP:0009025) | 3.45579568 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.40524718 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.40524718 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 3.36717820 |
| 34 | Deformed tarsal bones (HP:0008119) | 3.34944064 |
| 35 | Hyperammonemia (HP:0001987) | 3.32046392 |
| 36 | Hepatic necrosis (HP:0002605) | 3.31596276 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 3.30702966 |
| 38 | Dilated cardiomyopathy (HP:0001644) | 3.26700390 |
| 39 | Primary atrial arrhythmia (HP:0001692) | 3.25199127 |
| 40 | Supraventricular tachycardia (HP:0004755) | 3.18000849 |
| 41 | Hyperglycinuria (HP:0003108) | 3.17416762 |
| 42 | Type 1 muscle fiber predominance (HP:0003803) | 3.13377387 |
| 43 | Supraventricular arrhythmia (HP:0005115) | 3.10210787 |
| 44 | Bulbar palsy (HP:0001283) | 3.10144556 |
| 45 | Muscle stiffness (HP:0003552) | 3.10046758 |
| 46 | Myotonia (HP:0002486) | 3.08109556 |
| 47 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.06685119 |
| 48 | Nemaline bodies (HP:0003798) | 3.06431782 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04292006 |
| 50 | Bundle branch block (HP:0011710) | 3.03304507 |
| 51 | Absent phalangeal crease (HP:0006109) | 2.99789584 |
| 52 | Cerebral edema (HP:0002181) | 2.98610890 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.93274076 |
| 54 | Increased muscle lipid content (HP:0009058) | 2.92285853 |
| 55 | Syncope (HP:0001279) | 2.89764338 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88399865 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.88399865 |
| 58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.87803457 |
| 59 | Atrioventricular block (HP:0001678) | 2.82926466 |
| 60 | Heart block (HP:0012722) | 2.81501222 |
| 61 | Malignant hyperthermia (HP:0002047) | 2.81154106 |
| 62 | Acute encephalopathy (HP:0006846) | 2.75161320 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.70517692 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.70342950 |
| 65 | Xanthomatosis (HP:0000991) | 2.64859700 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.64383836 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.63321378 |
| 68 | Prolonged QT interval (HP:0001657) | 2.60870139 |
| 69 | Difficulty climbing stairs (HP:0003551) | 2.60694630 |
| 70 | Ventricular arrhythmia (HP:0004308) | 2.60525724 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.56256291 |
| 72 | Hypoalphalipoproteinemia (HP:0003233) | 2.54480031 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.53954609 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.53732889 |
| 75 | Hyperglycinemia (HP:0002154) | 2.52772222 |
| 76 | Frequent falls (HP:0002359) | 2.52394905 |
| 77 | Deep venous thrombosis (HP:0002625) | 2.50383007 |
| 78 | Generalized muscle weakness (HP:0003324) | 2.45597801 |
| 79 | Metabolic acidosis (HP:0001942) | 2.45479515 |
| 80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.44977270 |
| 81 | Abnormality of the calcaneus (HP:0008364) | 2.43546492 |
| 82 | Distal arthrogryposis (HP:0005684) | 2.41790366 |
| 83 | Ragged-red muscle fibers (HP:0003200) | 2.41421525 |
| 84 | Achilles tendon contracture (HP:0001771) | 2.39373318 |
| 85 | Lactic acidosis (HP:0003128) | 2.38838859 |
| 86 | Myopathic facies (HP:0002058) | 2.35975460 |
| 87 | Abnormal finger flexion creases (HP:0006143) | 2.35239286 |
| 88 | Scapular winging (HP:0003691) | 2.32975272 |
| 89 | Cholelithiasis (HP:0001081) | 2.32877740 |
| 90 | Spinal rigidity (HP:0003306) | 2.31200882 |
| 91 | Lethargy (HP:0001254) | 2.27794750 |
| 92 | Abnormality of the foot musculature (HP:0001436) | 2.27644191 |
| 93 | Lower limb amyotrophy (HP:0007210) | 2.26859882 |
| 94 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26006717 |
| 95 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24945690 |
| 96 | Areflexia of lower limbs (HP:0002522) | 2.24406958 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.23486052 |
| 98 | Mitochondrial inheritance (HP:0001427) | 2.22753195 |
| 99 | Gout (HP:0001997) | 2.22125769 |
| 100 | Foot dorsiflexor weakness (HP:0009027) | 2.22113424 |
| 101 | Hypolipoproteinemia (HP:0010981) | 2.17339215 |
| 102 | Increased CSF lactate (HP:0002490) | 2.16295836 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15765665 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.14812285 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 2.14571411 |
| 106 | Ventricular fibrillation (HP:0001663) | 2.14239011 |
| 107 | Late onset (HP:0003584) | 2.14234789 |
| 108 | Gowers sign (HP:0003391) | 2.11270391 |
| 109 | Neck muscle weakness (HP:0000467) | 2.09211838 |
| 110 | Progressive macrocephaly (HP:0004481) | 2.07798932 |
| 111 | Progressive muscle weakness (HP:0003323) | 2.07309084 |
| 112 | Distal lower limb muscle weakness (HP:0009053) | 2.05829524 |
| 113 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.05463306 |
| 114 | Round ear (HP:0100830) | 2.05065103 |
| 115 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03739439 |
| 116 | Limb-girdle muscle atrophy (HP:0003797) | 2.02798830 |
| 117 | Exercise intolerance (HP:0003546) | 2.02346146 |
| 118 | Fetal akinesia sequence (HP:0001989) | 2.00540258 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99904259 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.99904259 |
| 121 | Hyperalaninemia (HP:0003348) | 1.99904259 |
| 122 | Abnormality of serum amino acid levels (HP:0003112) | 1.99124297 |
| 123 | Testicular atrophy (HP:0000029) | 1.96846730 |
| 124 | Waddling gait (HP:0002515) | 1.96808535 |
| 125 | Vomiting (HP:0002013) | 1.95517985 |
| 126 | Weak cry (HP:0001612) | 1.93074393 |
| 127 | Stridor (HP:0010307) | 1.91690066 |
| 128 | Slender build (HP:0001533) | 1.89228225 |
| 129 | Metatarsus adductus (HP:0001840) | 1.84811633 |
| 130 | Fatigable weakness (HP:0003473) | 1.81577982 |
| 131 | Abnormality of the neuromuscular junction (HP:0003398) | 1.81577982 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.81205475 |
| 133 | Cholecystitis (HP:0001082) | 1.81205475 |
| 134 | Easy fatigability (HP:0003388) | 1.78728142 |
| 135 | Diaphragmatic weakness (HP:0009113) | 1.75306299 |
| 136 | Generalized amyotrophy (HP:0003700) | 1.71706735 |
| 137 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.69269526 |
| 138 | Muscular dystrophy (HP:0003560) | 1.65841495 |
| 139 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65382395 |
| 140 | Reticulocytosis (HP:0001923) | 1.63044296 |
| 141 | Adducted thumb (HP:0001181) | 1.59798861 |
| 142 | Hyperkalemia (HP:0002153) | 1.57424826 |
| 143 | Abnormality of glycolysis (HP:0004366) | 1.56907960 |
| 144 | Proximal amyotrophy (HP:0007126) | 1.54664734 |
| 145 | Paralysis (HP:0003470) | 1.53078634 |
| 146 | Shoulder girdle muscle weakness (HP:0003547) | 1.51949432 |
| 147 | Hip contracture (HP:0003273) | 1.51813109 |
| 148 | Breech presentation (HP:0001623) | 1.49155923 |
| 149 | Pelvic girdle muscle weakness (HP:0003749) | 1.45564738 |
| 150 | Congenital hip dislocation (HP:0001374) | 1.44835384 |
| 151 | Muscle fiber atrophy (HP:0100295) | 1.42438379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.56664035 |
| 2 | BCKDK | 5.07618679 |
| 3 | OBSCN | 4.12688315 |
| 4 | PHKG1 | 3.92128787 |
| 5 | PHKG2 | 3.92128787 |
| 6 | TRIB3 | 3.44126195 |
| 7 | PDK3 | 3.08261952 |
| 8 | PDK4 | 3.08261952 |
| 9 | PKN2 | 2.98915598 |
| 10 | LMTK2 | 2.62935942 |
| 11 | MYLK | 2.40687648 |
| 12 | PINK1 | 2.32084805 |
| 13 | MAP2K3 | 1.99315063 |
| 14 | MUSK | 1.93863192 |
| 15 | NEK1 | 1.93398258 |
| 16 | DMPK | 1.91549921 |
| 17 | IRAK3 | 1.88808434 |
| 18 | PDK2 | 1.76910579 |
| 19 | PIK3CA | 1.71277971 |
| 20 | ERN1 | 1.65221915 |
| 21 | MAP3K7 | 1.64286822 |
| 22 | TIE1 | 1.62070196 |
| 23 | SIK1 | 1.50948437 |
| 24 | SCYL2 | 1.50197296 |
| 25 | EPHA2 | 1.47754315 |
| 26 | RPS6KB2 | 1.47431295 |
| 27 | FLT3 | 1.43584698 |
| 28 | SMG1 | 1.42769750 |
| 29 | PIK3CG | 1.42184380 |
| 30 | PRPF4B | 1.31952252 |
| 31 | MAPK12 | 1.31167133 |
| 32 | STK24 | 1.26063950 |
| 33 | ARAF | 1.24989451 |
| 34 | CCNB1 | 1.22879729 |
| 35 | MAPKAPK3 | 1.20194191 |
| 36 | RIPK1 | 1.19312531 |
| 37 | FGFR4 | 1.16349618 |
| 38 | TESK1 | 1.13175389 |
| 39 | INSRR | 1.12575809 |
| 40 | NME1 | 1.06434418 |
| 41 | NME2 | 1.05415335 |
| 42 | ILK | 1.03121408 |
| 43 | LIMK1 | 1.03009700 |
| 44 | VRK2 | 1.02639434 |
| 45 | PRKAA2 | 1.01065020 |
| 46 | MAP3K3 | 0.97656037 |
| 47 | PRKD1 | 0.93385405 |
| 48 | KDR | 0.90711885 |
| 49 | MAPK11 | 0.88087475 |
| 50 | PRKAA1 | 0.87646666 |
| 51 | NEK9 | 0.82692972 |
| 52 | MAP2K6 | 0.80536013 |
| 53 | EEF2K | 0.76841571 |
| 54 | MAP2K4 | 0.75951639 |
| 55 | TESK2 | 0.75673416 |
| 56 | CAMK2D | 0.75248869 |
| 57 | MAP3K5 | 0.74731742 |
| 58 | TGFBR2 | 0.73653754 |
| 59 | BRAF | 0.72171378 |
| 60 | EIF2AK1 | 0.72158192 |
| 61 | MAP3K11 | 0.70147889 |
| 62 | EPHB1 | 0.69020266 |
| 63 | TBK1 | 0.65684164 |
| 64 | PTK6 | 0.65438715 |
| 65 | PAK3 | 0.64563709 |
| 66 | WNK4 | 0.64172239 |
| 67 | MAP3K10 | 0.63204834 |
| 68 | KSR2 | 0.60859020 |
| 69 | GRK7 | 0.56449108 |
| 70 | TRPM7 | 0.54390819 |
| 71 | IRAK2 | 0.53801858 |
| 72 | CAMK4 | 0.53412393 |
| 73 | DAPK3 | 0.52425266 |
| 74 | CAMK2B | 0.52357386 |
| 75 | CAMK2G | 0.52310325 |
| 76 | ICK | 0.51770482 |
| 77 | PDPK1 | 0.50558649 |
| 78 | CDK8 | 0.50356184 |
| 79 | CDK12 | 0.50038897 |
| 80 | STK4 | 0.49286833 |
| 81 | CDK7 | 0.49236066 |
| 82 | TYK2 | 0.49043772 |
| 83 | LRRK2 | 0.47892394 |
| 84 | RPS6KL1 | 0.47540190 |
| 85 | RPS6KC1 | 0.47540190 |
| 86 | ROCK1 | 0.46590060 |
| 87 | MOS | 0.46580671 |
| 88 | LATS2 | 0.46536953 |
| 89 | CDC7 | 0.46129382 |
| 90 | RPS6KA6 | 0.46099946 |
| 91 | MAP2K1 | 0.43348856 |
| 92 | RAF1 | 0.43226988 |
| 93 | AURKA | 0.42988490 |
| 94 | JAK2 | 0.41789702 |
| 95 | PDK1 | 0.41690870 |
| 96 | CAMK1D | 0.41572635 |
| 97 | MAPK4 | 0.41174160 |
| 98 | PRKACG | 0.40797466 |
| 99 | PKN1 | 0.40651348 |
| 100 | AKT2 | 0.40592548 |
| 101 | MARK2 | 0.39824695 |
| 102 | MAP3K13 | 0.37759615 |
| 103 | MAP4K1 | 0.35716931 |
| 104 | MST1R | 0.35138187 |
| 105 | PRKG2 | 0.35022477 |
| 106 | PRKACB | 0.34179462 |
| 107 | TAOK1 | 0.33149019 |
| 108 | PRKD2 | 0.32926493 |
| 109 | MAP3K1 | 0.32018945 |
| 110 | JAK1 | 0.32000685 |
| 111 | PRKD3 | 0.31403986 |
| 112 | PRKCI | 0.31270754 |
| 113 | CAMK1 | 0.31127168 |
| 114 | STK38L | 0.30343937 |
| 115 | PDGFRA | 0.29572729 |
| 116 | PIM2 | 0.29521119 |
| 117 | RPS6KA1 | 0.29222906 |
| 118 | MAP3K6 | 0.27833004 |
| 119 | PRKACA | 0.27480478 |
| 120 | MAPKAPK5 | 0.27354973 |
| 121 | TAOK2 | 0.25283025 |
| 122 | RPS6KB1 | 0.25056840 |
| 123 | KIT | 0.24804835 |
| 124 | ABL2 | 0.24357402 |
| 125 | TAOK3 | 0.24182193 |
| 126 | MAP3K8 | 0.22882339 |
| 127 | MAPK10 | 0.22880563 |
| 128 | DYRK1B | 0.22341129 |
| 129 | PBK | 0.21289933 |
| 130 | MTOR | 0.21244976 |
| 131 | PAK4 | 0.19967263 |
| 132 | PRKCH | 0.19884313 |
| 133 | AURKB | 0.19661308 |
| 134 | STK38 | 0.19575531 |
| 135 | MAP2K2 | 0.19320619 |
| 136 | MAPK7 | 0.16709013 |
| 137 | RPS6KA2 | 0.15672414 |
| 138 | BTK | 0.15305234 |
| 139 | CDC42BPA | 0.14899695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.27729592 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.79891427 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.63848737 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.61227630 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.49164656 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.22390004 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77203362 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.55250740 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.42071489 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36849107 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.19279327 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17706966 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17052848 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14399410 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.00076847 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86764825 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85358332 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84900787 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.81555524 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.76072979 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74498386 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74367594 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70510223 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67597772 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63380885 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58990670 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57967251 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.51240855 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50933014 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.49053735 |
| 31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.47641328 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47005203 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.45710942 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 1.42670593 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34847696 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.33945179 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33038499 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.29354464 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18078547 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18004570 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14879332 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11354039 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07025836 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06785859 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05526587 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05361554 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01470989 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97957194 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93628331 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92880899 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.89433439 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88189255 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87746492 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87535630 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.86531647 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85507832 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85438012 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.84946873 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83645473 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82731888 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81335181 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81264985 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80986980 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80735119 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77853832 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74366678 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.72762107 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72543636 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72460726 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72260624 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.71920379 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70460017 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69795915 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68901761 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.67255040 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64979470 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64644653 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62386165 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60710248 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60648206 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60311474 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60080917 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60075791 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59746828 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59340154 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59203274 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57644629 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55973902 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55440104 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54384085 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53256209 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50764003 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48950345 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.48530344 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47529584 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47188290 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.43539204 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42977111 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40900102 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.40071504 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39845057 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39691444 |
| 103 | Mismatch repair_Homo sapiens_hsa03430 | 0.38803193 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38742617 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.37879310 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35989184 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35824300 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35191620 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34525882 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33213760 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31651138 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28760370 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20600477 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19833886 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.18379435 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17079892 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16323798 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.15820644 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.14604770 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14430347 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.14172844 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10220479 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.09992711 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06072336 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.05695536 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.05192121 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03670704 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.02232645 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01082735 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.00871098 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.00357429 |
| 132 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0793520 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | -0.0763103 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0574429 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0117688 |

